John S Davies
13PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Apr 09, 2025
CD22 TCR-engineered T cells exert antileukemia cytotoxicity without causing inflammatory responses.Kilyna A Nguyen, Zhihui Liu, John S Davies
|Nov 18, 2024
Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants.Ling Zhang, Scott M Norberg, Farrah Karimipour
|Jun 10, 2024
Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege.David Rutkowski, Rachel Scholey, John Davies
|Mar 15, 2024
Preclinical and translational pharmacology of afucosylated anti-CCR8 antibody for depletion of tumour-infiltrating regulatory T cells.Gautham Gampa, Phillip Spinosa, Jennifer Getz
|Dec 06, 2023
Publisher Correction: CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.Guillaume Gaud, Sooraj Achar, François X P Bourassa
|Nov 09, 2023
CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.Guillaume Gaud, Sooraj Achar, François X P Bourassa
Pageof 3
Frequent Collaborators
4 joint publications
Sooraj R Achar
4 joint publications
Naomi Taylor
4 joint publications
Christian S Hinrichs
4 joint publications
Grégoire Altan-Bonnet
4 joint publications
Scott Norberg
3 joint publications
François X P Bourassa
2 joint publications
Guillaume Gaud
2 joint publications
Paul Juneau
2 joint publications
Dorian B McGavern
2 joint publications
Paul E Love
